The Bombay Burma

Is Bombay Burmah overvalued or undervalued?

As of February 13, 2024, Bombay Burmah's valuation has shifted to very expensive, indicating it is overvalued at a price of 2014.35, despite a lower PE ratio compared to peers like Hindustan Unilever and Nestle India, and a strong ROCE of 50.63%.

As of 13 February 2024, the valuation grade for Bombay Burmah has moved from very attractive to very expensive, indicating a significant shift in its market perception. The company is currently deemed overvalued based on its financial metrics. Key ratios include a PE Ratio of 12.26, an EV to EBITDA of 4.40, and a ROE of 20.11%. <BR><BR>When compared to its peers, Bombay Burmah's valuation stands out as it has a much lower PE ratio compared to Hindustan Unilever at 53.88 and Nestle India at 75.2, both of which are also classified as very expensive. Despite a strong ROCE of 50.63%, the overall valuation suggests that the stock may not justify its current price of 2014.35, especially given its recent performance against the Sensex, where it has underperformed in the year-to-date period.

Who are the top shareholders of the Bombay Burmah?

The top shareholders of Bombay Burmah include Nowrosjee Wadia & Sons Limited with 38.97%, 171 foreign institutional investors owning 9.6%, and Acacia Institutional Partners, Lp as the largest public shareholder at 1.5%. Individual investors hold 11.66% of the shares, while mutual funds have a combined stake of 0.37%.

The top shareholders of Bombay Burmah include the promoters, with Nowrosjee Wadia & Sons Limited holding the largest stake at 38.97%. Additionally, the company has 171 foreign institutional investors (FIIs) collectively owning 9.6% of the shares. Mutual funds are represented by 13 schemes, which hold 0.37%. The highest public shareholder is Acacia Institutional Partners, Lp, with a stake of 1.5%. Individual investors also hold a significant portion, accounting for 11.66% of the shares.

how big is Bombay Burmah?

As of Jun 06, Bombay Burmah Trading Corporation Ltd has a market capitalization of 13,816.93 Cr, with recent net sales of 18,298.00 Cr and a net profit of 1,122.63 Cr for the latest four quarters.

Market Cap: As of Jun 06, Bombay Burmah Trading Corporation Ltd has a market capitalization of 13,816.93 Cr, classifying it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported a sum of Net Sales of 18,298.00 Cr and a sum of Net Profit of 1,122.63 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending in Mar'24. The Shareholder's Funds are valued at 4,676.13 Cr, while the Total Assets amount to 11,915.73 Cr.

What does Bombay Burmah do?

Bombay Burmah Trading Corporation Limited (BBTCL) is a mid-cap company involved in plantations, auto electric components, healthcare, and real estate, with recent net sales of ₹4,519 Cr and a net profit of ₹309 Cr for March 2025. Key metrics include a P/E ratio of 12.00 and a market cap of ₹13,834 Cr.

Overview: <BR>Bombay Burmah Trading Corporation Limited (BBTCL) is a multi-product and multi-divisional organization engaged in plantations, auto electric components, healthcare, and real estate within the FMCG industry and classified as a mid-cap company.<BR><BR>History: <BR>Bombay Burmah Trading Corporation was incorporated in the 19th century and has evolved through various business interests. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 4,519 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 309 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 13,834 Cr (Mid Cap)<BR><BR>Key Metrics: <BR>P/E: 12.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.92% <BR>Debt-Equity: -0.01 <BR>Return on Equity: 20.11% <BR>Price to Book: 2.45<BR><BR>Contact Details: <BR>Address: 9 Wallace Street, Fort Mumbai Maharashtra : 400001 <BR>Phone: 91-22-22197101 <BR>Email: bbtcl@bom2.vsnl.net.in /investorser <BR>Website: http://www.bbtcl.com

Who are in the management team of Bombay Burmah?

As of March 2022, the management team of Bombay Burmah includes Nusli N Wadia (Chairman), Ness N Wadia (Managing Director), and several independent directors, along with the Company Secretary, Murli Manohar Purohit, overseeing the company's operations and strategy.

As of March 2022, the management team of Bombay Burmah includes the following individuals:<BR><BR>1. Nusli N Wadia - Chairman (Non-Executive)<BR>2. Ness N Wadia - Managing Director<BR>3. Minnie Bodhanwala - Director<BR>4. Rajesh Batra - Independent Director<BR>5. Y S P Thorat - Independent Director<BR>6. Vinesh Kumar Jairath - Independent Director<BR>7. Chandra Iyengar - Independent Director<BR>8. Murli Manohar Purohit - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Has Bombay Burmah declared dividend?

Bombay Burmah Trading Corporation Ltd has declared a 200% dividend, amounting to ₹4 per share, with an ex-date of March 27, 2025. The company has shown varying total returns over different periods, with a total return of 31.12% over the past year.

Bombay Burmah Trading Corporation Ltd has declared a 200% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 4<BR>- Ex-date: 27 Mar 25<BR><BR>Dividend Yield: 0.92%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -15.85%, the dividend return was 0.72%, resulting in a total return of -15.13%.<BR><BR>Over the past year, the price return was 30.01%, the dividend return was 1.11%, leading to a total return of 31.12%.<BR><BR>In the last 2 years, the price return was 110.67%, the dividend return was 1.85%, culminating in a total return of 112.52%.<BR><BR>For the 3-year period, the price return stood at 99.38%, the dividend return at 2.31%, resulting in a total return of 101.69%.<BR><BR>In the 4-year span, the price return was 54.34%, the dividend return was 1.59%, giving a total return of 55.93%.<BR><BR>Finally, over the last 5 years, the price return was 81.02%, the dividend return was 2.23%, leading to a total return of 83.25%.<BR><BR>Overall, Bombay Burmah has shown a significant dividend declaration alongside varying total returns across different periods, indicating a mix of performance in terms of price appreciation and dividend income.

Who are the peers of the Bombay Burmah?

The peers of Bombay Burmah include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Jyothy Labs, Zydus Wellness, CCL Products, Avanti Feeds, and Honasa Consumer, with Bombay Burmah showing the highest 1-year return at 37.16%. Management risk varies from excellent to average among peers, with growth generally below average.

Peers: The peers of Bombay Burmah are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Jyothy Labs, Zydus Wellness, CCL Products, Avanti Feeds, and Honasa Consumer.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, Britannia Inds., while Good management risk is found at Hind. Unilever, Godrej Consumer, Jyothy Labs, CCL Products, and Avanti Feeds, and the rest have Average management risk. Growth is Average at Nestle India, while Below Average growth is noted at Hind. Unilever, ITC, Britannia Inds., Godrej Consumer, Bombay Burmah, Jyothy Labs, Zydus Wellness, CCL Products, Avanti Feeds, and Honasa Consumer. Excellent capital structure is seen at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Bombay Burmah, Jyothy Labs, Zydus Wellness, Avanti Feeds, and Honasa Consumer, while CCL Products has Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Bombay Burmah at 37.16%, while the peer with the lowest is Honasa Consumer at -32.21%. Bombay Burmah's return is significantly higher than Honasa Consumer's. Additionally, the six-month return is negative for Bombay Burmah, Jyothy Labs, and Zydus Wellness.

Is Bombay Burmah technically bullish or bearish?

As of November 3, 2025, the market trend is mildly bearish, indicated by daily moving averages and weekly Dow Theory, despite mixed signals from the MACD and RSI suggesting a cautious outlook.

As of 3 November 2025, the technical trend has changed from sideways to mildly bearish. The current technical stance is mildly bearish, driven by the daily moving averages indicating a bearish outlook and the weekly Dow Theory also reflecting a mildly bearish sentiment. The MACD shows a bullish signal on the weekly but is mildly bearish on the monthly, while the RSI is bullish on the monthly but shows no signal on the weekly. Overall, the mixed signals from the indicators suggest a cautious bearish outlook, with the strength of the bearish trend being mild.

How has been the historical performance of Bombay Burmah?

Bombay Burmah has shown steady growth in net sales and operating income from Mar'19 to Mar'25, with operating profit and profit before tax significantly improving. After a loss in Mar'23, profit after tax rebounded to 2,050.54 Cr in Mar'25, reflecting a recovery in financial health and operational efficiency.

Answer:<BR>The historical performance of Bombay Burmah shows a steady increase in net sales, rising from 11,423.20 Cr in Mar'19 to 18,298.01 Cr in Mar'25. Total operating income has similarly grown, reaching 18,298.01 Cr in Mar'25 from 11,423.20 Cr in Mar'19. The total expenditure has also increased, but at a slower rate, from 9,740.65 Cr in Mar'19 to 15,162.41 Cr in Mar'25. Operating profit, excluding other income, has shown a positive trend, increasing from 1,682.55 Cr in Mar'19 to 3,135.60 Cr in Mar'25, although it peaked at 3,497.70 Cr in Mar'24. Profit before tax has also improved significantly, from 1,674.85 Cr in Mar'19 to 2,907.90 Cr in Mar'25, while profit after tax has rebounded from a loss of 1,675.73 Cr in Mar'23 to a profit of 2,050.54 Cr in Mar'25. The earnings per share (EPS) reflect this recovery, moving from -240.08 in Mar'23 to 160.95 in Mar'25. The company's total assets have decreased from 15,676.75 Cr in Mar'23 to 12,686.88 Cr in Mar'25, while total liabilities have also decreased from 15,676.75 Cr in Mar'23 to 12,686.88 Cr in Mar'25. Cash flow from operating activities has improved, reaching 2,277.00 Cr in Mar'25, compared to 1,409.00 Cr in Mar'20.<BR><BR>Breakdown:<BR>Bombay Burmah's financial performance over the years indicates a robust growth trajectory in net sales, which increased consistently from 11,423.20 Cr in Mar'19 to 18,298.01 Cr in Mar'25. This growth in sales has been accompanied by a rise in total operating income, which reached the same figure as net sales by Mar'25. While total expenditure has risen, the operating profit has shown a commendable increase, particularly from Mar'21 to Mar'25, highlighting the company's ability to manage costs effectively. The profit before tax has also seen a significant rise, reflecting improved operational efficiency and profitability. After experiencing a substantial loss in Mar'23, the profit after tax rebounded strongly in Mar'25, demonstrating a recovery in the company's financial health. The earnings per share have mirrored this recovery, showcasing a positive shift from negative to strong positive values. Despite a decrease in total assets and liabilities from their peak in Mar'23, the company has maintained a healthy cash flow from operating activities, indicating solid operational performance. Overall, the data reflects a company on a path of recovery and growth, with improved profitability and operational efficiency.

When is the next results date for The Bombay Burmah Trading Corporation Ltd?

The next results date for The Bombay Burmah Trading Corporation Ltd is 13 February 2026.

The next results date for The Bombay Burmah Trading Corporation Ltd is scheduled for 13 February 2026.

Are The Bombay Burmah Trading Corporation Ltd latest results good or bad?

The latest results for The Bombay Burmah Trading Corporation Ltd show a strong profit increase of 43.84% year-on-year, but a revenue decline of 4.89% from the previous quarter and slight margin compression raise concerns about sustainability, leading to a cautious market sentiment and a "SELL" rating.

The latest results for The Bombay Burmah Trading Corporation Ltd present a mixed picture. On one hand, the company reported a consolidated net profit of ₹443.96 crores for Q4 FY26, which is a significant increase of 43.84% year-on-year and a 40.35% rise from the previous quarter. This indicates strong operational performance and improved efficiency.<BR><BR>However, the quarterly revenue of ₹4,817.99 crores reflects a decline of 4.89% compared to the previous quarter, although it shows a year-on-year growth of 6.62%. The operating margin has also compressed slightly to 17.4%, down from 17.98% a year ago, indicating some pressure on profitability due to rising costs and competitive challenges in the FMCG sector.<BR><BR>Overall, while the profit growth is encouraging, the decline in revenue and margin compression raises concerns about the sustainability of this performance. The market sentiment appears cautious, reflected in a "SELL" rating and an overall score of 35 out of 100, suggesting that investors should be wary of potential challenges ahead.

Should I buy, sell or hold The Bombay Burmah Trading Corporation Ltd?

Which are the latest news on The Bombay Burma?

Why is The Bombay Burmah Trading Corporation Ltd falling/rising?

As of 16-May, The Bombay Burmah Trading Corporation Ltd's stock price is declining, currently at 1,522.80, due to underperformance in the market, concerns over growth and valuation, and low institutional support. Despite a slight positive return over the past month, the stock has significantly underperformed over the year.

As of 16-May, The Bombay Burmah Trading Corporation Ltd's stock price is falling, currently at 1,522.80, which reflects a decrease of 15.35 or 1.0%. This decline can be attributed to several factors highlighted in the provided data. <BR><BR>Firstly, the stock has underperformed its sector by 1.16% today and has experienced a trend reversal after two consecutive days of gains, indicating a shift in market sentiment. Additionally, while the stock has shown some positive movement over the past month with a return of 1.76%, it has significantly underperformed over the year, with a return of -17.22%, compared to the Sensex's -8.84%. <BR><BR>The company's financial health also raises concerns, as it has demonstrated poor long-term growth, with net sales and operating profit growing at annual rates of only 7.84% and 7.04%, respectively, over the last five years. Furthermore, the stock's valuation appears expensive with a Price to Book Value of 1.5, despite trading at a discount compared to its peers' average historical valuations. <BR><BR>Investor participation has increased, with a delivery volume rise of 20.35% against the 5-day average, but this has not translated into a positive price movement. The company's low stake held by domestic mutual funds, at only 1.67%, may indicate a lack of confidence among institutional investors regarding the stock's current price or business outlook. <BR><BR>Overall, the combination of underperformance in the market, concerns over growth and valuation, and a lack of institutional support contributes to the stock's current decline.